BC Cancer - Kelowna (Sindi Ahluwalia Hawkins Centre)

399 Royal Avenue
Kelowna, BC, V1Y 5L3

Clinical Trial Unit Manager
Agnes Sauter
250-712-3927
Agnes.Sauter@bccancer.bc.ca

Prostate

PROTRACT (Prostate Cancer Treatment Optimization via Analysis of Circulating Tumour DNA) Study: A Randomized Phase II Trial Comparing Biomarker Directed Therapy versus Clinician's Choice of Enzalutamide or Docetaxel in Patients with Advanced Prostate Cancer Post-Abiraterone

Cancer Type
Prostate
Phase II
Recruiting Dates
BC Cancer - Victoria
Open Recruiting Date
BC Cancer - Vancouver
Open Recruiting Date
BC Cancer - Surrey
Open Recruiting Date
BC Cancer - Kelowna (Sindi Ahluwalia Hawkins Centre)

CONTACT-02: A Phase 3, Randomized, Open-Label, Controlled Study of Cabozantinib (XL184) in Combination With Atezolizumab vs Second Novel Hormonal Therapy (NHT) in Subjects With Metastatic Castration-Resistant Prostate Cancer

Cancer Type
Prostate
Phase III
Recruiting Dates
BC Cancer - Kelowna (Sindi Ahluwalia Hawkins Centre)
Open Recruiting Date

CAPltello-281: A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib+Abiraterone Versus Placebo+Abiraterone as Treatment for Patients With DeNovo Metastatic Hormone-Sensitive Prostate Cancer Characterised by PTEN Deficiency.

Cancer Type
Prostate
Phase III
Recruiting Dates
BC Cancer - Vancouver
Open Recruiting Date
BC Cancer - Kelowna (Sindi Ahluwalia Hawkins Centre)

AMPLITUDE: A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Cancer Type
Prostate
Phase III
Recruiting Dates
BC Cancer - Vancouver
Open Recruiting Date
BC Cancer - Kelowna (Sindi Ahluwalia Hawkins Centre)
BC Cancer - Victoria
Open Recruiting Date
Back to top